Hypertension Center Events

Cedars-Sinai Hypertension Center 2017 Clinical Highlights Symposium

Friday, Feb. 24, 2017, 7:15 a.m.-3:15 p.m.
Harvey Morse Auditorium, Cedars-Sinai Medical Center
8701 Gracie Allen Drive, Los Angeles, CA 90048

Despite significant advances in research, hypertension remains a leading cause of death worldwide. The Cedars-Sinai Hypertension Center 2017 Clinical Highlights Symposium will provide participants with a comprehensive review of the latest diagnostic and therapeutic approaches to this complex and multifaceted disease. Course content will explore blood pressure monitoring and resistant hypertension, general pharmacotherapy, primary aldosteronism, hypertension in chronic kidney disease, hypertensive heart disease, renovascular hypertension and other relevant topics such as lifestyle modifications. Special emphasis will be placed on the clinical recognition, evaluation and management of adrenal hypertension, including aldosterone producing adenoma and pheochromocytoma. The course format will consist of case-based lectures reviewing the latest evidence, recommendations and scientific principles, and will provide clinicians will effective strategies to incorporate into daily medical practice.

The Cedars-Sinai Hypertension Center is the only hypertension program in California to be certified as a Comprehensive Hypertension Center by the American Society of Hypertension—the largest organization of clinical hypertension specialists and hypertension investigators in the United States. The Cedars-Sinai Hypertension Center provides comprehensive multispecialty consultative care for patients with difficult-to-treat hypertension, secondary hypertension, and related conditions. The center also has innovative National Institutes of Health-funded research programs ranging from basic science on the immunologic basis of hypertension to a randomized clinical trial of a community-based barber-pharmacist-physician team approach to improve hypertension management in African-American men.

Cedars-Sinai Hypertension Center 2016 Clinical Highlights Symposium

Friday, Feb. 26, 2016, 7:15 a.m.-3:15 p.m.
Harvey Morse Auditorium, Cedars-Sinai Medical Center
8701 Gracie Allen Drive, Los Angeles, CA 90048

Hypertension remains the leading preventable cause of cardiovascular disease and death in the world. The inaugural Cedars-Sinai Hypertension Center 2016 Clinical Highlights Symposium will provide participants with a comprehensive review of the latest diagnostic and therapeutic approaches to this complex and multifaceted disease, using a case-based approach.

Course content will include an update on the latest evidence from recent landmark clinical trials and state-of-the-art approaches to the diagnosis and management of hypertension in clinical practice. Topics will include the landmark SPRINT trial, drug and non-drug therapy, drug-resistant hypertension (including percutaneous intervention), adrenal hypertension, renal and renovascular hypertension.

The course format will be case-based lectures reviewing the latest evidence, recommendations and scientific principles to guide therapy for a wide-range of ambulatory patients with hypertension.

The Cedars-Sinai Hypertension Center is the only hypertension program in California to be certified as a Comprehensive Hypertension Center by the American Society of Hypertension (ASH)-the largest organization of clinical hypertension specialists and hypertension investigators in the United States. The Cedars-Sinai Hypertension Center provides comprehensive multi-specialty consultative care for patients with difficult-to-treat hypertension, secondary hypertension, and related conditions. The Center also has innovative National Institutes of Health-funded research programs ranging from basic science on the immunologic basis of hypertension to a randomized clinical trial of a community-based barber-pharmacist-physician team approach to improve hypertension management in African-American men.

Presentations:

  • Michael A. Weber, MD—Hypertension Guidelines 2016
  • Stanley S. Franklin, MD, FACP, FACC, FASN—Blood Pressure Measurement: Avoiding Errors of White-Coat and Masked Hypertension
  • Ronald Victor, MD—Hypertension Pharmacotherapy: A Practical Approach
  • Michael A. Weber, MD—Cedars-Sinai Diabetes
  • Run Yu, MD, PhD—Pheochromocytoma and paraganglioma
  • Odelia Cooper, MD—Primary Aldosteronism
  • Vito M. Campese, MD—Renovascular Hypertension: Is there still room for interventions?
  • Florian Rader, MD, MSc—Hypertensive Heart Disease
  • Sheila Kar, MD FACC—Lifestyle Modification & Non-Drug Therapy
  • Anthony Reid, MD—Managing Hypertension in African American Patients
  • Vito M. Campese, MD—Hypertension in Chronic Kidney Disease